Legislative Activity

This resolution formally condemns socialism in all its forms, asserting that its ideology is incompatible with American values and the U.S. Constitution. It reaffirms the necessity of secure, citizen-only elections and calls for the enactment of the SAVE America Act to prevent noncitizen voting and strengthen election integrity.

The Doug LaMalfa Federal Disaster Tax Relief Certainty Act provides tax relief to individuals affected by federally declared disasters occurring between 2019 and 2027. The bill allows taxpayers to deduct qualified disaster-related casualty losses even if they do not itemize and excludes certain wildfire relief payments from gross income. These measures aim to reduce the financial burden on disaster victims by simplifying the deduction process and preventing the taxation of recovery compensation.

This resolution designates the first week of August as "National Community Health Center Week" to honor the vital role these centers play in providing comprehensive primary care to millions of Americans. It celebrates the 60-year legacy of community health centers in improving public health outcomes, supporting local economies, and expanding access to essential services. The bill encourages all Americans to visit their local centers and recognize the dedicated staff and partners who make this care possible.

This resolution formally honors the courage and sacrifice of U.S. veterans who served during the Korean War and those who have served in Korea since the 1953 armistice. It seeks to ensure these service members receive the recognition they deserve for their vital role in defending democracy and freedom on the Korean Peninsula.

The Stop EU Overreach Act mandates that the United States Trade Representative (USTR) launch a formal Section 301 investigation into the extraterritorial impact of various European Union environmental and sustainability regulations on U.S. businesses. The bill seeks to address concerns that these EU mandates impose unfair, burdensome, and conflicting requirements on U.S. companies for operations occurring outside of Europe. If the investigation confirms these practices harm U.S. commerce, the USTR is authorized to take retaliatory trade actions to eliminate those burdens.

The Stop Support for UNRWA Act of 2026 prohibits the United States from providing any voluntary or assessed contributions to the United Nations Relief and Works Agency (UNRWA). While it bars direct funding to the agency, the bill allows for humanitarian aid to be delivered through alternative organizations, provided they are certified to be free of ties to terrorism, violence, or antisemitism.

The Stealth Bot Prohibition Act bans the use of automated bots that access websites without proper disclosure or that intentionally impersonate human users. This legislation empowers the Federal Trade Commission and state attorneys general to enforce these rules through civil penalties and legal action to protect digital platforms from deceptive or harmful automated activity.

The Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 extends vital funding for ALS research and clinical trial programs through 2031. This legislation strengthens oversight by enhancing grant review processes, improving safety reporting requirements, and mandating a comprehensive five-year FDA action plan to accelerate the development of treatments for rare neurodegenerative diseases.

The STRATA Act of 2026 establishes a State Department-led program to strengthen national security and economic competitiveness by partnering with trusted allies to develop secure, diversified critical mineral supply chains. The legislation fosters innovation through international research centers, streamlined technology adoption, and a digital platform for American businesses, while strictly prohibiting participation from adversarial nations. To ensure ongoing oversight, the Act includes a ten-year sunset provision that requires Congress to review and reauthorize these initiatives in the future.

The "Combating Illicit Xylazine Act" aims to combat the illegal use of xylazine by adding it to Schedule III of the Controlled Substances Act, which would allow for increased regulation and tracking of the substance. The bill includes exemptions and delayed effective dates for certain requirements to ease the transition for legitimate users, such as veterinarians and animal handlers. It also directs the Sentencing Commission to review sentencing guidelines for xylazine-related offenses and mandates reports to Congress on the prevalence and impact of illicit xylazine use. Finally, it will include xylazine in Arcos tracking.

Tyler's Law mandates a comprehensive study by the Secretary of Health and Human Services on the frequency, cost, and impact of fentanyl testing in hospital emergency departments during overdose cases. Following the study, the Secretary must issue guidance on whether routine fentanyl testing should become standard practice for overdose patients. This guidance will also address staff training regarding existing drug test panels and the long-term health implications of such testing.

The Helping Educators Respond to Overdoses (HERO) Act establishes a federal grant program to help schools purchase opioid overdose reversal drugs and develop comprehensive emergency response plans. Additionally, the bill mandates that educational institutions receiving federal funds report the distribution of these life-saving medications to designated national health and safety databases.

The AADAPT Act expands access to specialized dementia care by authorizing grants for public and nonprofit health centers to integrate these services into their programs. Additionally, the bill extends federal funding authorization through 2031 to ensure the continued growth and sustainability of these critical health outcomes.

The Stem Cell Therapeutic and Research Reauthorization Act of 2025 extends critical funding and support for the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory through 2031. This legislation modernizes the management of cord blood supplies by prioritizing clinical utility, genetic diversity, and the use of the latest scientific standards. By streamlining inventory operations, the bill ensures that life-saving transplant resources remain accessible and effective for patients in need.

The FDA Modernization Act 3.0 directs the FDA to update federal regulations by replacing references to "animal testing" with the broader term "nonclinical tests." This update ensures regulatory consistency with modern testing standards and includes a technical correction to the Federal Food, Drug, and Cosmetic Act.

The Destruction of Hazardous Imports Act authorizes the Secretary of Health and Human Services to mandate the destruction of imported goods that pose a significant public health risk and have been refused admission into the U.S. This legislation removes the option for owners to export these hazardous items and requires them to cover all destruction costs. Owners are granted due process through formal notice and hearing procedures before any destruction order is finalized.

The Patients First Act of 2026 is comprehensive legislation designed to stabilize Medicare physician payments, improve patient access to primary care, and transition the current quality reporting system to a more clinician-led framework. By modernizing reimbursement formulas, reducing financial volatility for providers, and increasing transparency in value-based care models, the bill aims to ensure a more sustainable and predictable healthcare environment. These reforms seek to lower out-of-pocket costs for patients while supporting the long-term viability of medical practices.

The Improving Seniors’ Timely Access to Care Act of 2025 aims to streamline and modernize the prior authorization process within Medicare Advantage plans. This bill mandates the adoption of electronic prior authorization systems and significantly increases transparency regarding approval rates and decision times starting in 2027. Furthermore, it establishes new enrollee protections and grants the Secretary authority to enforce faster decision timeframes for medical services.

The Chloe Cole Act of 2026 establishes a federal private right of action allowing individuals to sue healthcare professionals and institutions for damages related to gender-transition medical interventions performed on them as minors. The bill permits lawsuits regardless of when the intervention occurred and sets a statute of limitations extending 25 years past the individual's 18th birthday. Additionally, it mandates strict liability for such interventions performed after the Act's enactment.

The Protecting Privacy in Purchases Act prohibits payment card networks and processors from assigning specific merchant category codes to firearms retailers. This legislation aims to protect consumer privacy by preventing the tracking of firearm and ammunition purchases through specialized financial classification. The Attorney General is tasked with enforcing these provisions and reporting annually on compliance.